Healthcare Sep 26, 2022 09:27 PM (GMT+8) · EqualOcean
Cardioacc (Chinese: 心寰科技) announced the completion of an angel round financing exclusively invested by BioVenture (Chinese: 元生创投). WinX Capital (Chinese: 凯乘资本) served as the financial adviser. This fund will be used to promote the research and development of intracardiac echocardiography (ICE) products. Founded in October 2021, Cardioacc possesses more than 20 core invention patents and has initially completed the construction of crucial product technologies such as electromagnetic positioning and imaging algorithms. As a new interventional imaging technology, ICE catheter imaging can provide real-time, intuitive and high-resolution anatomical information.